ALKS

#1105
Alkermes plc - Ordinary Shares
42.6 9 USD
+6.89%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
42.19
42.83
년간 변동
25.16
42.83
일일 변동
+6.89%
월간 변동
+25.97%
6달 변화
+45.70%
년간 변동율
+41.12%
이전 종가
39.9 4
Open
42.3 3
저가
42.1 9
High
42.8 3
양
829
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 7.12 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
19.57
주가매출액비율
3.2

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

뉴스